Related references
Note: Only part of the references are listed.REGN-COV2, a Neutralizing Antibody Cocktail, in Outpatients with Covid-19
D. M. Weinreich et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
A Neutralizing Monoclonal Antibody for Hospitalized Patients with Covid-19
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Tocilizumab in Patients Hospitalized with Covid-19 Pneumonia
Carlos Salama et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Rapid GMP-Compliant Expansion of SARS-CoV-2-Specific T Cells From Convalescent Donors for Use as an Allogeneic Cell Therapy for COVID-19
Rachel S. Cooper et al.
FRONTIERS IN IMMUNOLOGY (2021)
SARS-CoV-2-Specific Memory T Lymphocytes From COVID-19 Convalescent Donors: Identification, Biobanking, and Large-Scale Production for Adoptive Cell Therapy
C. Ferreras et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)
Vaccinated and Convalescent Donor-Derived Severe Acute Respiratory Syndrome Coronavirus 2-Specific T Cells as Adoptive Immunotherapy for High-Risk Coronavirus Disease 2019 Patients
Penelope-Georgia Papayanni et al.
CLINICAL INFECTIOUS DISEASES (2021)
Adoptive transfer of ex vivo expanded SARS-CoV-2-specific cytotoxic lymphocytes: A viable strategy for COVID-19 immunosuppressed patients?
Manuel Guerreiro et al.
TRANSPLANT INFECTIOUS DISEASE (2021)
Rapid generation of multivirus-specific T lymphocytes for the prevention and treatment of respiratory viral infections
Spyridoula Vasileiou et al.
HAEMATOLOGICA (2020)
Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals
Alba Grifoni et al.
CELL (2020)
Clinical Features of Maintenance Hemodialysis Patients with 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China
Jun Wu et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2020)
Clinical and immunological features of severe and moderate coronavirus disease 2019
Guang Chen et al.
JOURNAL OF CLINICAL INVESTIGATION (2020)
SARS-CoV-2: a storm is raging
Savannah F. Pedersen et al.
JOURNAL OF CLINICAL INVESTIGATION (2020)
COVID-19 Therapeutic Options Under Investigation
Malak Kaddoura et al.
FRONTIERS IN PHARMACOLOGY (2020)
Specific donor HLA allotypes as predictors of cytomegalovirus disease risk in acute myeloid leukemia
Gi-June Min et al.
HLA (2020)
Phenotype and kinetics of SARS-CoV-2-specific T cells in COVID-19 patients with acute respiratory distress syndrome
Daniela Weiskopf et al.
SCIENCE IMMUNOLOGY (2020)
SARS-CoV-2-reactive T cells in healthy donors and patients with COVID-19
Julian Braun et al.
NATURE (2020)
A systematic review of antibody mediated immunity to coronaviruses: kinetics, correlates of protection, and association with severity
Angkana T. Huang et al.
NATURE COMMUNICATIONS (2020)
SARS-CoV-2-specific T cells are rapidly expanded for therapeutic use and target conserved regions of the membrane protein
Michael D. Keller et al.
BLOOD (2020)
Dexamethasone in hospitalised patients with COVID-19: addressing uncertainties
Michael A. Matthay et al.
LANCET RESPIRATORY MEDICINE (2020)
Tocilizumab in patients with severe COVID-19: a retrospective cohort study
Giovanni Guaraldi et al.
LANCET RHEUMATOLOGY (2020)
Adoptive T Cell Therapy Strategies for Viral Infections in Patients Receiving Haematopoietic Stem Cell Transplantation
Giorgio Ottaviano et al.
CELLS (2019)
Mini bank of only 8 donors supplies CMV-directed T cells to diverse recipients
Ifigeneia Tzannou et al.
BLOOD ADVANCES (2019)
Virus-Specific T Cells: Broadening Applicability
A. John Barrett et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2018)
T cells for viral infections after allogeneic hematopoietic stem cell transplant
Catherine M. Bollard et al.
BLOOD (2016)
Virus-specific T-cell banks for 'off the shelf' adoptive therapy of refractory infections
R. J. O'Reilly et al.
BONE MARROW TRANSPLANTATION (2016)
A flow-cytometry based cytotoxicity assay using stained effector cells in combination with native target cells
M Höppner et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2002)
Share Paper
